Insights

This study used recurrence plot analysis to classify cardiomyopathy patients. The method accurately distinguished between ischemic and dilated cardiomyopathy, suggesting potential for early disease prognosis.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Data Science

Background:

  • Cardiovascular diseases significantly impact the elderly, with early cardiomyopathy prognosis remaining a challenge.
  • Distinguishing between different types of cardiomyopathy, such as ischemic (ICM) and dilated (DCM), is crucial for effective treatment.
  • Recurrence plot analysis offers a novel approach to characterizing complex physiological signals.

Purpose of the Study:

  • To classify cardiomyopathy patients based on etiology using significant indexes from recurrence plot characterization.
  • To differentiate between ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) patients.
  • To assess the utility of recurrence plot analysis in distinguishing cardiomyopathy patients from healthy controls.

Main Methods:

  • Extracted beat-to-beat (BBI), systolic blood pressure (SBP), diastolic blood pressure (DBP), and respiratory flow (FLW) time series from 39 cardiomyopathy patients (24 ICM, 15 DCM) and 39 controls.
  • Calculated recurrence plots for each signal and characterized them using 12 indexes.
  • Developed support vector machine (SVM) models using the best classifiers for patient classification.

Main Results:

  • The optimal SVM model achieved 92.3% accuracy, 95.8% sensitivity, and 86.6% specificity in classifying ICM versus DCM patients.
  • When comparing all cardiomyopathy patients (CMP) against control subjects (CON), the best model demonstrated 85.8% accuracy, 92.3% sensitivity, and 80.1% specificity.
  • Analysis suggested a more deterministic signal behavior in DCM patients compared to ICM patients.

Conclusions:

  • Recurrence plot analysis, utilizing physiological time series, is a promising tool for classifying cardiomyopathy subtypes.
  • The developed SVM models show high accuracy in differentiating between ICM and DCM, and between patients and controls.
  • These findings support the clinical relevance of recurrence plot characterization for improving cardiomyopathy prognosis and patient stratification.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
42
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
22
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
38
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27